Charles Willard Shrode, MD | |
191 Biltmore Ave, Asheville, NC 28801-4109 | |
(828) 254-0881 | |
(828) 254-1614 |
Full Name | Charles Willard Shrode |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 10 Years |
Location | 191 Biltmore Ave, Asheville, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295930956 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 2014-00926 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Digestive Health Partners Pa | 1254244056 | 60 |
News Archive
DICOM Grid, provider of a cloud-based platform for medical imaging management, today announced the general availability of DICOM Grid™ ImageCare™, the first secure, scalable cloud computing platform that makes searching, sharing and exchanging medical images as easy as using consumer web applications such as Google, Facebook and iTunes.
A new study by researchers at Emory's Rollins School of Public Health and the Centers for Disease Control and Prevention shows that lifestyle modification programs modeled on diabetes prevention programs trials not only achieved weight reduction, but also additional metabolic benefits -specifically, reductions in blood sugar, blood pressure, and cholesterol levels.
Hispanic patients were 57 percent less likely than Caucasian patients to undergo coronary artery bypass surgery (CABG) one year after successful angioplasty, a type of percutaneous coronary intervention (PCI) to open blockages in the coronary arteries.
While cigarette smoking continues to be the leading cause of preventable disease, disability and death in the U.S., the evidence base for cessation support has revealed that telephone call centers, or "quitlines," have been a particularly successful intervention, according to the Centers for Disease Control and Prevention, which recently published a compilation of scientific research in the American Journal of Preventive Medicine.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today it has initiated its ATHENA natural history of disease study in patients with Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
› Verified 2 days ago
Entity Name | Digestive Health Partners Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326037680 PECOS PAC ID: 1254244056 Enrollment ID: O20031107000467 |
News Archive
DICOM Grid, provider of a cloud-based platform for medical imaging management, today announced the general availability of DICOM Grid™ ImageCare™, the first secure, scalable cloud computing platform that makes searching, sharing and exchanging medical images as easy as using consumer web applications such as Google, Facebook and iTunes.
A new study by researchers at Emory's Rollins School of Public Health and the Centers for Disease Control and Prevention shows that lifestyle modification programs modeled on diabetes prevention programs trials not only achieved weight reduction, but also additional metabolic benefits -specifically, reductions in blood sugar, blood pressure, and cholesterol levels.
Hispanic patients were 57 percent less likely than Caucasian patients to undergo coronary artery bypass surgery (CABG) one year after successful angioplasty, a type of percutaneous coronary intervention (PCI) to open blockages in the coronary arteries.
While cigarette smoking continues to be the leading cause of preventable disease, disability and death in the U.S., the evidence base for cessation support has revealed that telephone call centers, or "quitlines," have been a particularly successful intervention, according to the Centers for Disease Control and Prevention, which recently published a compilation of scientific research in the American Journal of Preventive Medicine.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today it has initiated its ATHENA natural history of disease study in patients with Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Charles Willard Shrode, MD 191 Biltmore Ave, Asheville, NC 28801-4109 Ph: (828) 254-0881 | Charles Willard Shrode, MD 191 Biltmore Ave, Asheville, NC 28801-4109 Ph: (828) 254-0881 |
News Archive
DICOM Grid, provider of a cloud-based platform for medical imaging management, today announced the general availability of DICOM Grid™ ImageCare™, the first secure, scalable cloud computing platform that makes searching, sharing and exchanging medical images as easy as using consumer web applications such as Google, Facebook and iTunes.
A new study by researchers at Emory's Rollins School of Public Health and the Centers for Disease Control and Prevention shows that lifestyle modification programs modeled on diabetes prevention programs trials not only achieved weight reduction, but also additional metabolic benefits -specifically, reductions in blood sugar, blood pressure, and cholesterol levels.
Hispanic patients were 57 percent less likely than Caucasian patients to undergo coronary artery bypass surgery (CABG) one year after successful angioplasty, a type of percutaneous coronary intervention (PCI) to open blockages in the coronary arteries.
While cigarette smoking continues to be the leading cause of preventable disease, disability and death in the U.S., the evidence base for cessation support has revealed that telephone call centers, or "quitlines," have been a particularly successful intervention, according to the Centers for Disease Control and Prevention, which recently published a compilation of scientific research in the American Journal of Preventive Medicine.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today it has initiated its ATHENA natural history of disease study in patients with Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
› Verified 2 days ago
Dr. William R Harlan Iii, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 191 Biltmore Ave, Asheville, NC 28801 Phone: 828-254-0881 Fax: 828-254-1614 | |
Dr. Nellie E. L. Fleming, MD Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville Hospitalist Group, Asheville, NC 28801 Phone: 828-213-4411 Fax: 828-285-9740 | |
Dr. Wade H Saunders Iii, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-274-6000 Fax: 828-277-6350 | |
Marianne Soufas, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 68 Sweeten Creek Rd, Asheville, NC 28803 Phone: 828-274-9567 Fax: 828-255-2865 | |
Dr. Bryan J Pace, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-274-6000 Fax: 828-274-6025 | |
Zachary Dillon Glenn, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1111 | |
Dr. Jeffrey Tyler Ramsey, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 123 Hendersonville Rd, Asheville, NC 28803 Phone: 828-407-2415 Fax: 828-412-4171 |